UNSPSC 51334415: Rilapine
Commodity
Code facts
- Part of
-
-
51000000
-
51330000
- 51334400
-
51330000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51334415
Definition
This classification denotes an antipsychotic agent with the molecular formula C22H20ClN3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7QCG0RP106, chemically known as (z)-2-chloro-10-(4-methyl-1-piperazinyl)-5h-dibenzo(a,d)cycloheptene-(delta(sup 5,alpha))-acetonitrile but generally known as rilapine, which bears US NIH Compound Identifier 6446980. European Medicines Agency schedules Rilapine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10313MIG.
Read the full definition
The term RILAPINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). RILAPINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule rilapine under HS 29335995 and SITC 51576. As of Q4 2014, RILAPINE remains the US FDA Preferred Term for this commodity. Rilapine bears US NLM identifiers UMLS ID C2699086 and NCI Concept Code C76445. SMILES: CLC1CC2C=C(N3CCN(CC3)C)C3C(/C(=C/C#N)C2CC1)CCCC3.
About UNSPSC 51334415
UNSPSC 51334415 Rilapine is a Commodity code under which state and local governments procure pharmaceutical products and medical supplies, though the recent sourcing activity reflects a mismatch between the code's nominal scope and actual purchasing patterns. The single recent opportunity shows Seminole County, Florida using this code to solicit naloxone and drug deactivation systems for community health delivery rather than rilapine specifically. State and local issuers using this code span county health departments and municipal community health agencies seeking to address opioid response and harm reduction through competitive bidding. The work involves supply procurement with quarterly delivery schedules, unit pricing, and standard compliance requirements including drug-free workplace certification, E-Verify authorization, workers' compensation, commercial general liability, and professional liability insurance.
Seminole County, Florida represents the only recent activity supporting this code's procurement footprint. The county issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding with quarterly deliveries to the Seminole County Community Health Building at 520 W. Lake Mary Blvd, Sanford, Florida 32771. The IFB response deadline was July 26, 2023, at 2:00 pm, with vendors required to submit bids electronically through the county's e-Procurement Portal and include all shipping and delivery costs in their proposals. The contract structure includes an initial two-year term with a one-year renewal option and operates on a fixed-fee basis. The procurement carried potential FEMA funding and corresponding federal compliance requirements under the Clean Air Act and Federal Water Pollution Control Act, with three-month probationary termination rights reserved to the county.
Quick answers
What is UNSPSC 51334415?
UNSPSC 51334415 is Rilapine, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51334415?
UNSPSC 51334415 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).
On GovTribe
See everything under UNSPSC 51334415
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code